ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.122,25
0,95%
S&P 500
5.064,20
0,91%
US Dollar vs BRL
5,1116
0,00%
Bitcoin
59.780,41
1,12%
Brent Oil
83,775
0,17%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. BioNTech SE (BNTX)

  7. BioNTech SE (BNTX) Notícias

BNTX

BioNTech (BNTX)

BioNTech SE
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BNTX
DataHoraFonteTítuloCódigoCompanhia
26/04/202408:48IH Market NewsAnglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More NewsNASDAQ:BNTXBioNTech SE
24/04/202408:28IH Market NewsCoca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More NewsNASDAQ:BNTXBioNTech SE
22/04/202407:45GlobeNewswire Inc.BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024NASDAQ:BNTXBioNTech SE
07/04/202415:00GlobeNewswire Inc.Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic CancerNASDAQ:BNTXBioNTech SE
21/03/202408:17IH Market NewsApple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market UpdatesNASDAQ:BNTXBioNTech SE
20/03/202408:17IH Market NewsU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s Policy Update; Oil Prices DipNASDAQ:BNTXBioNTech SE
20/03/202407:15GlobeNewswire Inc.BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate UpdateNASDAQ:BNTXBioNTech SE
20/03/202407:00GlobeNewswire Inc.BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial OfficerNASDAQ:BNTXBioNTech SE
11/03/202410:04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BNTXBioNTech SE
11/03/202408:45GlobeNewswire Inc.BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024NASDAQ:BNTXBioNTech SE
11/03/202407:25PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 12, 2024 in BioNTech Lawsuit - BNTXNASDAQ:BNTXBioNTech SE
07/03/202408:45GlobeNewswire Inc.BioNTech Announces Planned Retirement of Sean MarettNASDAQ:BNTXBioNTech SE
06/03/202408:45GlobeNewswire Inc.BioNTech to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 20, 2024NASDAQ:BNTXBioNTech SE
05/03/202407:45PR Newswire (US)The Gross Law Firm Reminds BioNTech SE Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 12, 2024 - BNTXNASDAQ:BNTXBioNTech SE
28/02/202420:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BNTXBioNTech SE
26/02/202407:45PR Newswire (US)Shareholders that lost money on BioNTech SE(BNTX) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:BNTXBioNTech SE
22/02/202407:45PR Newswire (US)BioNTech SE Sued for Securities Law Violations - Contact The Gross Law Firm Before March 12, 2024 to Discuss Your Rights - BNTXNASDAQ:BNTXBioNTech SE
15/02/202418:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BNTXBioNTech SE
14/02/202409:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BNTXBioNTech SE
09/02/202407:45PR Newswire (US)The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of BioNTech SE(BNTX) ShareholdersNASDAQ:BNTXBioNTech SE
08/02/202407:45GlobeNewswire Inc.BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs  NASDAQ:BNTXBioNTech SE
08/02/202407:45GlobeNewswire Inc.BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs NASDAQ:BNTXBioNTech SE
02/02/202407:45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of BioNTech SE of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2024 - (NASDAQ: BNTX)NASDAQ:BNTXBioNTech SE
31/01/202408:45GlobeNewswire Inc.BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305NASDAQ:BNTXBioNTech SE
22/01/202408:45GlobeNewswire Inc.BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast CancerNASDAQ:BNTXBioNTech SE
10/01/202408:21IH Market NewsWall Street Highlights: Tesla Launches Restyled Model 3, VinFast Unveils Pickup Prototype, and MoreNASDAQ:BNTXBioNTech SE
09/01/202416:57Dow Jones NewsBioNTech Shares Down 3.4%; Sees 2024 Revenue Below Wall Street ViewsNASDAQ:BNTXBioNTech SE
09/01/202408:45GlobeNewswire Inc.BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BNTXBioNTech SE
21/12/202310:00GlobeNewswire Inc.BioNTech and DualityBio Receive FDA Breakthrough Therapy Designation for Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Endometrial CancerNASDAQ:BNTXBioNTech SE
19/12/202314:12Dow Jones NewsCureVac Shares Hit All-Time Low on German Patent Court RulingNASDAQ:BNTXBioNTech SE
 Apresentando as notícias mais relevantes sobre:NASDAQ:BNTX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
BBDC4
BRADESCO PN
BOV
BEES3
BANESTES ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
COGN3
COGNA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados